ReShape Lifesciences Inc (RSLS) — Strategic Asset Allocation Index
ReShape Lifesciences Inc (RSLS) has a Strategic Asset Allocation Index of 14.2% as of June 2023. Strategic assets (PP&E of $956.00K plus long-term investments of $-) total $956.00K, measured against net assets of $6.74 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check ReShape Lifesciences Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
ReShape Lifesciences Inc Strategic Asset Allocation Index (2005–2022)
This chart shows how ReShape Lifesciences Inc's Strategic Asset Allocation Index has evolved across 18 annual periods from 2005 to 2022. As of June 2023, the index stands at 14.2%, representing strategic assets of $956.00K against net assets of $6.74 Million USD. See RSLS free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for ReShape Lifesciences Inc (2005–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for ReShape Lifesciences Inc from 2005 to 2022, covering 18 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see ReShape Lifesciences Inc market cap and net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 23.7% | $869.00K | $869.00K | $- | $3.66 Million | ▲ +20.0 pp |
| 2021 | 3.7% | $1.72 Million | $1.72 Million | $- | $46.07 Million | ▼ -0.3 pp |
| 2020 | 4.0% | $584.00K | $584.00K | $- | $14.49 Million | ▲ +4.0 pp |
| 2019 | 0.1% | $16.00K | $16.00K | $- | $24.11 Million | ▼ -0.1 pp |
| 2018 | 0.2% | $63.55K | $63.55K | $- | $31.66 Million | ▼ -0.4 pp |
| 2017 | 0.6% | $438.62K | $438.62K | $- | $76.37 Million | ▼ -6.3 pp |
| 2016 | 6.8% | $200.72K | $200.72K | $- | $2.94 Million | ▼ -2.1 pp |
| 2015 | 8.9% | $326.30K | $326.30K | $- | $3.67 Million | ▲ +1.7 pp |
| 2014 | 7.2% | $481.52K | $481.52K | $- | $6.66 Million | ▲ +3.3 pp |
| 2013 | 3.9% | $577.00K | $577.00K | $- | $14.68 Million | ▼ -1.2 pp |
| 2012 | 5.1% | $609.67K | $609.67K | $- | $11.88 Million | ▲ +2.0 pp |
| 2011 | 3.1% | $630.35K | $630.35K | $- | $20.04 Million | ▲ +0.6 pp |
| 2010 | 2.5% | $742.00K | $742.00K | $- | $29.71 Million | ▼ -14.8 pp |
| 2009 | 17.3% | $966.00K | $966.00K | $- | $5.58 Million | ▲ +6.2 pp |
| 2008 | 11.1% | $1.26 Million | $1.26 Million | $- | $11.41 Million | ▲ +7.8 pp |
| 2007 | 3.3% | $1.49 Million | $1.49 Million | $- | $45.28 Million | ▼ -0.6 pp |
| 2006 | 3.9% | $1.10 Million | $1.10 Million | $- | $28.57 Million | ▼ -28.7 pp |
| 2005 | 32.5% | $642.00K | $642.00K | $- | $1.97 Million | — |